ASND - Ascendis Pharma A S Stock Trading

Ascendis Pharma A/S(NASDAQ: ASND) stock trading, description, contact, officers and directors.

About Ascendis Pharma A/S

Not available

Stock Information

Ascendis Pharma A/S Company Name:

ASND Stock Symbol:

NASDAQ Market:

Ascendis Pharma A/S Website:

Get ASND Alerts

News, Short Squeeze, Breakout and More Instantly...

ASND - Ascendis Pharma A/S Announces Target Enrollment Achieved in the Phase 3 PaTHway Trial of TransCon(TM) PTH (palopegteriparatide) in Adults with Hypoparathyroidism (HP) and Provides a Comprehensive Global Clinical Program Update

– Ascendis expects to complete enrollment of subjects still in screening within one week – – PaTHway top-line data now anticipated in Q1 2022 and submission of a New Drug Application ( NDA ) in mid-2022 – – Announc...
ASND - Ascendis Pharma A/S Announces Extension of U.S. Food and Drug Administration Review Period for TransCon(TM) hGH (Lonapegsomatropin) for Pediatric Growth Hormone Deficiency

COPENHAGEN, Denmark, June 11, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to create new product candidates that address unmet medical needs, today announced that the U.S. Food and Drug Administra...
ASND - The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial

The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial PR Newswire 1. VISEN Pharmaceuticals has obtained the investigational new drug (IND) approval from the Center for Drug Evaluation (CDE) of the National...